In vivo tumor necrosis factor-alpha induction following chlorin e6 - Photodynamic therapy in Buffalo rats

Neoplasma

Volumn 44, Issue 3, 1997, Pages 192-196

  Zioikowski P ^a   Symonowicz, K ^a   Milach, J ^a   Zawirska, B ^a   Szkudlarek, T ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

photodynamic therapy; tumor necrosis factor alpha

Indexed keywords

CHLORIN E6; PHOTOSENSITIZING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; HEPATOMA CELL; INTRAVENOUS DRUG ADMINISTRATION; NECROSIS; NONHUMAN; PHOTODYNAMIC THERAPY; RAT;

EID: 0030862881     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ABRAHAMSSON, J., CARLSSON, B., MELLANDER, L.: Tumor-necrosis-factor-alpha in malignant disease. Am. J. Pediatr. Hematol. Oncol., 15, 1993, 364-369.
2. BERTON, G., GORDON, S.: Superoxide release by peritoneal and bone marrow-derived macrophages. Modulation by adherence and cell activation. Immunology, 49, 1983, 693-704.
3. CARSWELL, H.A., OLD, L.J., KASSEL, R.L., GREEN, S., FIORE, N., WILLIAMSON, B.: An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72, 1975, 3666-3670.
4. EVANS, S., MATTHEWS, W., PERRY, R., FRAKER, D., NORTON, J., PASS, H.I.: Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J. Natl. Cancer Inst., 82, 1990, 34-39.
5. HEINRICH, P.C., CASTELL, J.V., ANDUS, T.: Interleukin-6 and the acute phase response. Biochem. J., 265, 1990, 621-636.
6. LARRICK, J.W., WRIGHT, S.C.: Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J., 4, 1990, 3215-3223.
7. MILAS, L., WIKE, J., HUNTER, N., VOLPE, J., BASIC, I.: Macrophage content of murine sarcomas and carcinomas: Associations with tumor growth and tumor radiocurability. Cancer Res., 47, 1987, 1069-1075.
8. MORADI, M.M., CARSON, L.F., WEINBERG, B., HANEY, A.F., TWIGGS, L.B., RAMAKRISHNAN, S.: Serum and ascitic fluid levels of interleukin-1, interleukin-6 and tumor-necrosis-factor-alpha in patients with ovarian epithelial cancer. Cancer, 72, 1993, 2433-2440.
9. NIITSU, Y., WATANABE, N., SONE, H., NEDA, H., YAMAUCHI, N., URUSHIZAKI, I.: Mechanism of the cytotoxic effect of tumor necrosis factor. Gann, 76, 1985, 1193-1197.
10. NSEYO, U.O., WHALEN, R.K., DUNCAN, M.R., BERMAN, B., LUNDAHL, S.L.: Urinary cytokines following photodynamic therapy for bladder cancer. Urology, 36, 1990, 167-171.
11. POLLARD, J.K., MITCHELL, M.D.: Tumor necrosis factor-alpha stimulates amnion prostaglandin biosynthesis primarily via an action on fatty acid cyclooxygenase. Prostaglandins, 46, 1993, 499-510.
12. PUSZTAI, L., LEWIS, C.E., MCGEE, J.O.: Growth arrest of the breast cancer cell line, T 47D, by TNF-alpha; cell cycle specificity and signal transduction. Br. J. Cancer, 67, 1993, 290-296.
13. SCHULZE-OSTHOFF, K., BAKKER, A.C., VANHAESEBROECK, B., BEYAERT, R., JACOB, W.A., FIERS, W.: Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem.,267, 1992, 5317-5323.
14. SRINIVASAN, J.M., FAJARDO, L.F., HAHN, G.M.: Mechanism of antitumor activity of tumor necrosis factor-alpha with hyperthermia in a tumor necrosis factor-alpha -resistant tumor. J. Natl. Cancer Inst., 82, 1990, 1904-1910.
15. WATANABE, N., NIITSU, Y., UMENO, H., KURIYAMA, H., NEDA, H., YAMAUCHI, N., MAEDA, M., URUSHIZAKI, I.: Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res., 48, 1988, 2179-2183.
16. WIEGAND-STEUBING, R., YETURU, S., TUCCILLO, A., SUN, C.H., BERNS, M.W.: Activation of macrophages by Photofrin II during photodynamic therapy. J. Photochem. Photobiol. B. Biol., 10, 1991, 133-145.
17. WONG, G.H.W., ELWELL, J.H., OBERLEY, L.W., GOEDDEL, D.V.: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 58, 1989, 923-931.
18. 3-tetraphenylporphyrin on cells of transplantable mammary cancer. J. Physique, IV, 1991 (C7), 225-229.
19. ZIÓIKOWSKI, P., MILACH, J., SYMONOWICZ, K., CHMIELEWSKI, P., LATOS-GRAZYŃSKI, L., MARCINKOWSKA, E.: 5,20-Bis(4-sulphophenyl)-10,15-bis(2-methoxy-4-sulphophenyl)-21-thiaporphyrin as the new potent sensitizer in photodynamic therapy. Tumori, 81, 1995, 364-369.
20. 6 - photodynamic therapy in Balb/c mice. In; Photochemotherapy, Photodynamic Therapy and Other Modalities. Eds: Ehrenberg, B., Jori, G., Moan, J. Proc. SPIE, 2625. Bellingham, WA, 1996, 426-433.